{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:07:14Z","timestamp":1762866434397},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantationreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.trre.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T06:30:47Z","timestamp":1409121047000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Liver disease in kidney transplant recipients"],"prefix":"10.1016","volume":"29","author":[{"given":"Alan","family":"Gunderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2014.08.002_bb0005","first-page":"355","article-title":"The spectrum of chronic liver disease in renal transplant recipients","volume":"83","author":"Allison","year":"1992","journal-title":"Q J Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0010","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2014.08.002_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.51.3.429","article-title":"Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients","volume":"51","author":"Hinrichsen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.trre.2014.08.002_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-59745-394-3_4","article-title":"Nomenclature and numbering of the hepatitis C virus","volume":"510","author":"Kuiken","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.trre.2014.08.002_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223-235.2000","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.trre.2014.08.002_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2893.2005.00604.x","article-title":"Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis","volume":"12","author":"Derbala","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.trre.2014.08.002_bb0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/382544","article-title":"Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin","volume":"189","author":"Legrand-Abravanel","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199208063270601","article-title":"The declining risk of post-transfusion hepatitis C virus infection","volume":"327","author":"Donahue","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0055","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJM199608293350904","article-title":"Hepatitis C virus-associated fulminant hepatic failure","volume":"335","author":"Farci","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(94)91224-6","article-title":"Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children","volume":"343","author":"Lai","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2014.08.002_bb0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-199510000-00007","article-title":"The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation","volume":"60","author":"Periera","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.ajkd.2005.11.008","article-title":"The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study","volume":"47","author":"Delladetsima","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.trre.2014.08.002_bb0090","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1097\/01.ASN.0000012382.97168.E0","article-title":"Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus","volume":"13","author":"Bloom","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2014.08.002_bb0095","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/ndt\/13.7.1872","article-title":"Tuberculosis after renal transplantation: experience of one Turkish centre","volume":"13","author":"Yildiz","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","article-title":"Hepatitis C and renal disease: an update","volume":"42","author":"Meyers","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0105","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0110","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0115","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/00007890-199812270-00021","article-title":"Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+recipients in renal transplantation","volume":"66","author":"Ali","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1399-0012.2000.14040602.x","article-title":"Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors","volume":"14","author":"Mandal","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ki.1995.29","article-title":"Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV","volume":"47","author":"Morales","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2014.08.002_bb0130","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-6143.2004.00652.x","article-title":"Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list","volume":"5","author":"Bloom","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0041-1345(00)00914-3","article-title":"Factors influencing response to hepatitis B virus vaccination in hemodialysis patients","volume":"32","author":"Sezer","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.08.002_bb0145","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.transproceed.2011.12.076","article-title":"Kidney transplantation in hepatitis C-positive recipients: does type of induction influence outcomes?","volume":"44","author":"Sureshkumar","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.08.002_bb0150","first-page":"16","article-title":"Impact of immunosuppressive therapy on hepatitis C infection after renal transplantation","volume":"75","author":"Kahraman","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2014.08.002_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ndt\/10.supp6.93","article-title":"Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients","volume":"10","author":"Rostaing","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.gtc.2004.04.011","article-title":"Treatment of chronic viral hepatitis in patients with renal disease","volume":"33","author":"Fabrizi","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.trre.2014.08.002_bb0165","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/hep.25962","article-title":"Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: results from the REALIZE trial","volume":"56","author":"De Meyer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.08.002_bb0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/apt.12354","article-title":"Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study","volume":"38","author":"Vera-Llonch","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.trre.2014.08.002_bb0175","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2012.05.011","article-title":"Factors that predict response of patients with hepatitis C virus infection to boceprevir","volume":"143","author":"Poordad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2014.08.002_bb0180","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.26096","article-title":"Anemia during treatment with peginterferon Alfa-2b\/ribavirin and boceprevir: analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial","volume":"57","author":"Sulkowski","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.08.002_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B, virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.trre.2014.08.002_bb0190","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/TP.0b013e3181b4749f","article-title":"Fatal human herpesvirus-6 infection after renal transplantation","volume":"88","author":"Pilmore","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007890-199607270-00025","article-title":"The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection","volume":"62","author":"Fornairon","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0272-6386(99)70312-4","article-title":"Protective effect of hepatitis B vaccine in chronic hemodialysis patients","volume":"33","author":"Miller","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0891-5520(05)70120-3","article-title":"Pyogenic liver abscesses","volume":"14","author":"Johannsen","year":"2000","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.trre.2014.08.002_bb0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2006.06.007","article-title":"Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States","volume":"131","author":"Nainan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2014.08.002_bb0215","doi-asserted-by":"crossref","first-page":"iii72","DOI":"10.1093\/ndt\/gfh1020","article-title":"The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure","volume":"19","author":"Morales","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0220","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.08.002_bb0225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/MEG.0b013e328133f091","article-title":"Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection","volume":"19","author":"Matos","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.trre.2014.08.002_bb0230","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ki.1993.190","article-title":"Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease","volume":"43","author":"Knudsen","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2014.08.002_bb0235","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/jhep.2002.36156","article-title":"Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients","volume":"36","author":"Chan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.08.002_bb0240","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1440-1746.1999.01960.x","article-title":"Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B","volume":"14","author":"Liaw","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.trre.2014.08.002_bb0245","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.TP.0000116448.97841.6D","article-title":"Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials","volume":"77","author":"Fabrizi","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0250","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5years of therapy","volume":"49","author":"Tenney","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.08.002_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000149370","article-title":"Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route","volume":"20","author":"Balayan","year":"1983","journal-title":"Intervirology"},{"key":"10.1016\/j.trre.2014.08.002_bb0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2008.09.010","article-title":"Acute hepatitis E in south-west France over a 5-year period","volume":"44","author":"Mansuy","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.trre.2014.08.002_bb0265","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0270","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","author":"Everson","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.08.002_bb0275","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.ajkd.2008.05.015","article-title":"Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history","volume":"52","author":"Reed","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0280","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2014.08.002_bb0285","first-page":"1282","article-title":"Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease","volume":"26","author":"Sherstha","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.08.002_bb0290","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1681\/ASN.V1191767","article-title":"Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma","volume":"11","author":"Chauveau","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2014.08.002_bb0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.trre.2014.08.002_bb0300","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0889-8553(03)00054-2","article-title":"Heritable disorders of the bile ducts","volume":"32","author":"Kamath","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.trre.2014.08.002_bb0305","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3748\/wjg.v13.i13.1934","article-title":"Clinical characteristics of Caroli's syndrome","volume":"13","author":"Yonem","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trre.2014.08.002_bb0315","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2014.08.002_bb0320","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2014.08.002_bb0325","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.trre.2014.08.002_bb0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2014.08.002_bb0335","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/00007890-200010270-00007","article-title":"A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients","volume":"70","author":"Sagedal","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0340","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910220305","article-title":"Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion","volume":"22","author":"Biggar","year":"1978","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2014.08.002_bb0345","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0350","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2165\/00128072-200103080-00004","article-title":"Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis","volume":"3","author":"Amir","year":"2001","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.trre.2014.08.002_bb0355","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/jcp.35.11.1190","article-title":"A prospective study of cytomegalovirus and herpes simplex virus disease in renal transplant recipients","volume":"35","author":"Walker","year":"1982","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trre.2014.08.002_bb0360","first-page":"2125","article-title":"Prevention of recurrent herpes infection after renal transplantation by low-dose oral acyclovir","volume":"26","author":"Jirasiritham","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.08.002_bb0365","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1001\/jama.1985.03360240047032","article-title":"Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir","volume":"254","author":"Seale","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2014.08.002_bb0370","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/infdis\/163.5.1001","article-title":"Herpes simplex virus hepatitis after solid organ transplantation in adults","volume":"163","author":"Kusne","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trre.2014.08.002_bb0375","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007890-200202270-00023","article-title":"Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature","volume":"73","author":"Fehr","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0380","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000658-199605000-00016","article-title":"Pyogenic hepatic abscess. Changing trends over 42years","volume":"223","author":"Huang","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2014.08.002_bb0385","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00007890-199911150-00009","article-title":"Tuberculosis in renal transplant recipients","volume":"68","author":"Sayiner","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.08.002_bb0390","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11255-004-6251-6","article-title":"Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient","volume":"36","author":"Agarwal","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.trre.2014.08.002_bb0395","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11906-013-0335-6","article-title":"Obesity and metabolic syndrome in kidney transplantation","volume":"15","author":"LaGuardia","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.trre.2014.08.002_bb0400","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/lt.20932","article-title":"De novo nonalcoholic fatty liver disease after liver transplantation","volume":"13","author":"Seo","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.08.002_bb0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.mehy.2013.11.039","article-title":"Nonalcoholic fatty liver disease (NAFLD): a new risk factor for adverse cardiovascular events in dialysis patients","volume":"82","author":"Mikolasevic","year":"2014","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.trre.2014.08.002_bb0410","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2014.08.002_bb0415","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2013.02.004","article-title":"Safety and efficacy of peginterferon-alpha2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C","volume":"58","author":"Sanai","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2014.08.002_bb0420","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3748\/wjg.14.255","article-title":"Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C","volume":"14","author":"Ayaz","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trre.2014.08.002_bb0425","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.transproceed.2007.07.013","article-title":"Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis","volume":"39","author":"Casanovas-Taltavull","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.08.002_bb0430","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2006.12.016","article-title":"The treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplant","volume":"46","author":"Rendina","year":"2007","journal-title":"J Hepatol"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X14000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X14000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T17:32:03Z","timestamp":1650043923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X14000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0955470X14000585"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2014.08.002","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver disease in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}